68Ga-labeled nectin-4 bicyclic peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-labeled nectin-4 bicyclic peptide, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression [NA]